Baidu
map

Neurology:男性更常见狭窄性颈动脉斑块

2013-04-19 高晓方 译 医学论坛网

  欧洲学者的一项研究表明。相当一部分青年卒中患者伴有动脉粥样硬化颈动脉狭窄和闭塞。论文于2013年3月6日在线发表于《神经病学》(Neurology)。   此项研究共纳入2187例卒中或短暂脑缺血发作(TIA)患者,其中男性为1319例,年龄为18至44岁者为744例。1612例(73.7%)患者接受附加颅内动脉超声检查。依据性别和年龄组(青年18~44岁;中年44~55岁)对患者进行分层。

  欧洲学者的一项研究表明。相当一部分青年卒中患者伴有动脉粥样硬化颈动脉狭窄和闭塞。论文于2013年3月6日在线发表于《神经病学》(Neurology)。

  此项研究共纳入2187例卒中或短暂脑缺血发作(TIA)患者,其中男性为1319例,年龄为18至44岁者为744例。1612例(73.7%)患者接受附加颅内动脉超声检查。依据性别和年龄组(青年18~44岁;中年44~55岁)对患者进行分层。

  结果显示,在缺血性卒中患者中,颈动脉狭窄和闭塞的总体发病率为8.9%(青年组4.9%;中年组11.0%),其中81%为症状性。男性出现非狭窄性颈动脉斑块较女性更为常见(15.8%对7.7%,P < 0.001),并且中年组患者较青年组更为常见(17.9%对4.9%,P < 0.001)。幕上颅内动脉狭窄和闭塞总计为11.8%。在中年组患者中幕上狭窄发生率更高(13.0%对7.8%,P < 0.001),闭塞发生率则等同于青年组。

颈动脉相关的拓展阅读: 


Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients
OBJECTIVE
Atherosclerosis is believed to be a minor cause of TIA and stroke in younger and middle-aged patients. However, data from large cohorts are limited. This study investigates the prevalence of extracranial and intracranial atherosclerosis in stroke and TIA patients aged 18-55 years in the multinational sifap1 study.
METHODS
From the sifap1 cohort (n = 5,023), we analyzed a subset of patients with complete data from carotid ultrasound studies. Patients with arterial dissections, vasculitis, and mobile thrombi were excluded. Among the remaining 2,187 patients (men: n = 1,319; 18-44 years: n = 744), intracranial arteries were additionally examined with ultrasonography in 1,612 patients (73.7%). Patients were stratified by sex and age groups (younger: 18-44 years; middle-aged: 45-55 years).
RESULTS
In patients with ischemic stroke, the overall prevalence of carotid artery stenoses and occlusions was 8.9% (younger: 4.9%; middle-aged: 11.0%), of which 81% were symptomatic. Nonstenotic carotid plaques were more common in men than in women (15.8% vs 7.7%; p < 0.001), and in middle-aged than in younger patients (17.0% vs 4.9%; p < 0.001). Supratentorial intracranial artery stenoses and occlusions amounted to 11.8%. Supratentorial stenoses occurred more frequently in middle-aged patients (13.0% vs 7.8%; p < 0.001), whereas occlusions were equally common (both 3.2%; not significant).
CONCLUSIONS
We observed a substantial proportion of atherosclerotic carotid artery stenoses and occlusions in younger stroke patients. Intracranial stenoses and occlusions were even more prevalent than extracranial carotid artery disease. Together with nonstenotic plaques, one-fifth of patients (21.2%) had symptomatic or asymptomatic large-artery atherosclerosis, which should encourage future stroke prevention campaigns to target risk factor modification in young people.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1843368, encodeId=5e0a18433685a, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon Nov 04 02:14:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999282, encodeId=de6b1999282b0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 04:14:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280756, encodeId=1abc1280e565e, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329991, encodeId=7cbe1329991f6, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1843368, encodeId=5e0a18433685a, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon Nov 04 02:14:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999282, encodeId=de6b1999282b0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 04:14:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280756, encodeId=1abc1280e565e, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329991, encodeId=7cbe1329991f6, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]
    2013-11-19 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1843368, encodeId=5e0a18433685a, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon Nov 04 02:14:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999282, encodeId=de6b1999282b0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 04:14:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280756, encodeId=1abc1280e565e, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329991, encodeId=7cbe1329991f6, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1843368, encodeId=5e0a18433685a, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon Nov 04 02:14:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999282, encodeId=de6b1999282b0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 04:14:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280756, encodeId=1abc1280e565e, content=<a href='/topic/show?id=c6ba1005490e' target=_blank style='color:#2F92EE;'>#颈动脉斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100549, encryptionId=c6ba1005490e, topicName=颈动脉斑块)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329991, encodeId=7cbe1329991f6, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Apr 21 00:14:00 CST 2013, time=2013-04-21, status=1, ipAttribution=)]

相关资讯

JAMA:减少动脉粥样硬化性血栓形成实现持续健康

  背景  β-阻滞剂仍是心肌梗死(MI)后的标准治疗。然而,β-阻滞剂用于无MI病史的冠心病(CAD)患者、有远期MI病史的患者以及仅有CAD危险因素的患者时的益处仍未明确。   目的  本研究旨在评价在有既往MI病史的患者、无MI病史的CAD患者以及仅有CAD危险因素的患者中,使用β-阻滞剂与心血管事件的相关性。   设计、条件与患者  这项纵向、观察性研究以

EMBO:揭示单核细胞迁移至血管壁导致动脉粥样硬化机制

在一项新的研究中,来自德国慕尼黑大学和荷兰阿姆斯特丹学术医学中心的研究人员首次阐明促进动脉粥样硬化产生的单核细胞如何找到通向血管壁的路径,在那里,它们促进阻塞性沉积物形成.相关研究结果于2013年2月18日在线发表在EMBO Molecular Medicine期刊上,论文标题为"Distinct functions of chemokine receptor axes in the athero

Sci Transl Med :迷你猪助力高胆固醇血症研究

近日,刊登在美国《科学—转化医学》上的一项新研究报告称,猪也会像人那样,发展出胆固醇增高及动脉粥样硬化(动脉堵塞)等症状。由于猪与人有着相似的生理机能,因此,来自丹麦的一组研究人员制造出一种迷你猪新模型,对诸如高胆固醇血症、动脉粥样硬化及心脏病等疾病新疗法的研究十分有帮助。新研究还使研发让体内粥样硬化可视化的成像技术成为可能。 奥尔胡斯大学临床医学部的Rozh Al-Mashhadi及其同事用一

Diabetes Care:T1DM患者维生素D代谢受损与动脉粥样硬化没有相关性

 1型糖尿病(T1DM)患者早发动脉粥样硬化的风险较高。已有的证据表明维生素D代谢受损可能会促进动脉粥样硬化的发生。来自美国华盛顿大学的Sachs博士等人进行了一项研究,测定T1DM患者血循环中维生素D代谢产物浓度与亚临床动脉粥样硬化间的联系。研究发现,维生素D代谢受损与动脉粥样硬化没有相关性。研究结果在线发表于2013年3月25日的美国《糖尿病护理》(Diabetes Care)杂志上

Osteoporos Int:男性血清骨钙蛋白与动粥相关

  最近的研究显示血清骨钙蛋白(OC)水平不仅仅与骨代谢相关,也与葡萄糖和脂肪代谢相关。然而,血清骨钙蛋白水平与动脉硬化的关系仍有争议。为了检测在2型糖尿病患者中,骨代谢指标包括骨钙蛋白是否与腹主动脉钙化指数相关,来自日本岛根大学医学部的Ogawa–Furuya N教授及其团队进行了一项研究,该研究认为,在男性2型糖尿病患者,血清骨钙蛋白和羧基化骨钙蛋白(ucOC)水平不仅有骨代谢相关,

Diabetes Care:胰岛移植或改善糖尿病相关动脉粥样硬化

  来自美国的一项研究表明,胰岛移植可能改善糖尿病相关的动脉粥样硬化。这可能通过恢复内源性胰岛素分泌,继以改善血糖控制,以及移植后优化的脂质调控予以实现。研究在2012年11月19日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究旨在评价对于无肾脏疾病的1型糖尿病患者,胰岛移植对颈动脉内膜中膜厚度(cIMT,作为动脉粥样硬化的标志)的影响。   研究连续纳入1

Baidu
map
Baidu
map
Baidu
map